Your own experience,
turned into knowledge
Conversation-based, data-driven support for everyday life.
Ryma is a platform that helps women going through menopause understand their hormonal health. Through ongoing conversations, Ryma automatically turns each woman's symptoms and lived experience into concrete knowledge she can act on. The result: better-informed decisions in her everyday life, a stronger foundation for personalised treatment and, over time, a better dataset for research.
And with understanding comes agency and a sense of being in control, towards yourself, your doctor, your partner and your employer.
Ryma is built for every woman, whether she is in perimenopause, menopause, or postmenopause.
Menopause is universal.
So is Ryma.
What you feel is real.
The numbers confirm it.
The KiSO study from the University of Copenhagen has mapped menopause in 153,800 Danish women. It is the largest study of its kind in Denmark, and the numbers paint a clear picture.
Most women are looking for understanding, of what is happening to their hormones and body, and help putting words to what they experience. The symptoms are widespread and last for years, but most are left without a clear picture of their own journey.
Ryma's clinical foundation
Ryma is built on the latest clinical knowledge of menopause and the menopausal transition. Ryma's answers follow the European clinical guidelines and the Danish DSOG guideline, which are based on peer-reviewed research. Ryma's advice is built on scientific sources. The clinical assessment belongs with the woman's own doctor.
Meet the woman behind Ryma.
I was the woman in the waiting room with 47 notes on my phone, trying to make sense of my own symptoms.
Most women going through menopause do not lack the will to act. They lack someone who can translate what the hormonal changes are doing to their body.
I never had time to fill in forms, and they never captured how I actually felt. With Ryma, I just talk. When I have a moment, when something happens, when I need answers. Ryma fits into my life, not the other way around. It remembers what I tell it and turns it into something I can act on.
We still know far too little about menopause, yet the knowledge we need already exists. Every woman holds it, in her body and her everyday life. Ryma builds that knowledge together with her. It helps her today, and over time it can drive better understanding, better guidance and better products, so the women who come after us start from a better place.
Menopause is universal. Ryma is for every woman, so we can grow wiser together.
Together we can change the standard and close the data gap in women’s health.
Research into menopause lacks longitudinal data from women’s everyday lives. We need to understand patterns over time. Symptom recall can be hard to remember and summarise in a consultation.
When you use Ryma, you can consent that your conversations generate anonymised, clinically relevant data about how menopause symptoms actually develop over time – closing an important data gap. You do it anonymously, but your patterns contribute to a research foundation that can change how we understand and treat menopause.
Be one of the first 1,000 users and help build Ryma.
- You shape the product. What works, what is missing, which questions Ryma should get better at asking, all based on what you actually need.
- You prove the model. Your retention, your insights, and your feedback are the foundation that keeps us running. The more women, the stronger the data, and the faster we can expand.
- You open the door for the next. Every user makes it possible for us to reach one more. The goal is to help every one of the 576,000 women in Denmark who want more clarity, insight, and help.
You deserve to understand, what your body is telling you.
Thousands of women carry symptoms they have no words for. Ryma has the language, and turns your words into insight you can act on. You get your own focus plan and your first report from day 1, so you can start to feel like yourself again.
Ryma launches in October. Join the waitlist to be among the first to get access.
